Logo image of CHS

Chicos FAS Inc (CHS) Stock Fundamental Analysis

NYSE:CHS - New York Stock Exchange, Inc. - US1686151028 - Common Stock - Currency: USD

7.59  -0.01 (-0.13%)

After market: 7.591 +0 (+0.01%)

Fundamental Rating

5

CHS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. CHS has an average financial health and profitability rating. CHS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CHS was profitable.
In the past year CHS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHS reported negative net income in multiple years.
Of the past 5 years CHS 4 years had a positive operating cash flow.
CHS Yearly Net Income VS EBIT VS OCF VS FCFCHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

CHS's Return On Assets of 8.82% is fine compared to the rest of the industry. CHS outperforms 79.84% of its industry peers.
The Return On Equity of CHS (26.40%) is better than 79.84% of its industry peers.
CHS has a better Return On Invested Capital (12.31%) than 77.52% of its industry peers.
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROIC 12.31%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
CHS Yearly ROA, ROE, ROICCHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

With a decent Profit Margin value of 5.29%, CHS is doing good in the industry, outperforming 72.87% of the companies in the same industry.
In the last couple of years the Profit Margin of CHS has grown nicely.
CHS's Operating Margin of 6.16% is fine compared to the rest of the industry. CHS outperforms 68.22% of its industry peers.
In the last couple of years the Operating Margin of CHS has grown nicely.
Looking at the Gross Margin, with a value of 38.94%, CHS is in line with its industry, outperforming 59.69% of the companies in the same industry.
CHS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
CHS Yearly Profit, Operating, Gross MarginsCHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

6

2. Health

2.1 Basic Checks

CHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CHS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHS has less shares outstanding
CHS has a better debt/assets ratio than last year.
CHS Yearly Shares OutstandingCHS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
CHS Yearly Total Debt VS Total AssetsCHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CHS has an Altman-Z score of 3.22. This indicates that CHS is financially healthy and has little risk of bankruptcy at the moment.
CHS's Altman-Z score of 3.22 is fine compared to the rest of the industry. CHS outperforms 70.54% of its industry peers.
CHS has a debt to FCF ratio of 0.42. This is a very positive value and a sign of high solvency as it would only need 0.42 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.42, CHS belongs to the best of the industry, outperforming 82.17% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that CHS is not too dependend on debt financing.
The Debt to Equity ratio of CHS (0.06) is better than 75.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Altman-Z 3.22
ROIC/WACC1.34
WACC9.19%
CHS Yearly LT Debt VS Equity VS FCFCHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.20 indicates that CHS should not have too much problems paying its short term obligations.
CHS has a worse Current ratio (1.20) than 72.09% of its industry peers.
A Quick Ratio of 0.42 indicates that CHS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.42, CHS is doing worse than 60.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.42
CHS Yearly Current Assets VS Current LiabilitesCHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The earnings per share for CHS have decreased strongly by -15.38% in the last year.
The Earnings Per Share has been growing slightly by 4.10% on average over the past years.
The Revenue has decreased by -0.24% in the past year.
The Revenue has been decreasing by -1.26% on average over the past years.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%

3.2 Future

CHS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.47% yearly.
The Revenue is expected to grow by 0.60% on average over the next years.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHS Yearly Revenue VS EstimatesCHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CHS Yearly EPS VS EstimatesCHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.86, which indicates a very decent valuation of CHS.
79.07% of the companies in the same industry are more expensive than CHS, based on the Price/Earnings ratio.
CHS is valuated cheaply when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
CHS is valuated reasonably with a Price/Forward Earnings ratio of 10.29.
Based on the Price/Forward Earnings ratio, CHS is valued a bit cheaper than 74.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CHS to the average of the S&P500 Index (21.38), we can say CHS is valued rather cheaply.
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
CHS Price Earnings VS Forward Price EarningsCHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CHS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHS is cheaper than 85.27% of the companies in the same industry.
CHS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHS is cheaper than 67.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 4.72
CHS Per share dataCHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CHS has a very decent profitability rating, which may justify a higher PE ratio.
CHS's earnings are expected to decrease with -8.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CHS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Chicos FAS Inc

NYSE:CHS (1/4/2024, 8:04:00 PM)

After market: 7.591 +0 (+0.01%)

7.59

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-30 2023-11-30/bmo
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
P/S 0.44
P/FCF 16.37
P/OCF 8.25
P/B 2.22
P/tB 2.34
EV/EBITDA 4.72
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROCE 15.79%
ROIC 12.31%
ROICexc 14.55%
ROICexgc 15.01%
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
FCFM 2.71%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Debt/EBITDA 0.14
Cap/Depr 134.65%
Cap/Sales 2.67%
Interest Coverage 35.98
Cash Conversion 66.14%
Profit Quality 51.32%
Current Ratio 1.2
Quick Ratio 0.42
Altman-Z 3.22
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%